Restrictive lung disfunction in metabolic syndrome and type II diabetes

S. Scarlata, F. L. Fimognari, R. Antonelli Incalzi (Rome, Colleferro, Italy)

Source: Annual Congress 2006 - Assessment in the chronic patient
Session: Assessment in the chronic patient
Session type: E-Posters in free access
Number: 514
Disease area: Airway diseases, Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Scarlata, F. L. Fimognari, R. Antonelli Incalzi (Rome, Colleferro, Italy). Restrictive lung disfunction in metabolic syndrome and type II diabetes. Eur Respir J 2006; 28: Suppl. 50, 514

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011


The metabolic syndrome and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020


Obesity and pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 194-207
Year: 2012


Pulmonary hypertension in patients with neurofibromatosis type I
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Respiratory muscle function in type 2 diabetes mellitus
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008

The heart in obesity hypoventilation syndrome
Source: Eur Respir Monogr 2020; 88: 143-153
Year: 2020


Pulmonary hypertension associated with neurofibromatosis type 1
Source: Eur Respir Rev, 27 (149) 180053; 10.1183/16000617.0053-2018
Year: 2018



Is lung a target organ in diabetes mellitus?
Source: Eur Respir J 2002; 20: Suppl. 38, 491s
Year: 2002

Pulmonary function and exercise tolerance in glycogenosis type II (GSDII)
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011


The type and severity of lung function disturbances in patients with Charcot-Marie-Tooth disease
Source: Eur Respir J 2005; 26: Suppl. 49, 66s
Year: 2005

The role of noninvasive ventilation in the management of type II respiratory failure in patients with myotonic dystrophy
Source: ERJ Open Res, 7 (3) 00192-2020; 10.1183/23120541.00192-2020
Year: 2021



Ventilatory response to hypercapnia in type 1 diabetes mellitus: role of autonomic neuropathy and metabolic control
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009



The association of pulmonary fibrosis with diabetes mellitus
Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020
Year: 2020



The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011

Metabolic syndrome and diabetes mellitus in COPD
Source: Eur Respir Mon 2013; 59: 117-134
Year: 2013


Chronic respiratory failure in myotonic dystrophy type 1 (DM1): Incidence & risk factors
Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation
Year: 2017

The impact of left heart dysfunction in patients with obesity hypoventilation syndrome with acute on chronic respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Association between type 2 diabetes and respiratory symptoms
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Peculiarities of diabetes mellitus in cystic fibrosis adults
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010


Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013